Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i
12 min.
Lipoprotein(a): Why Measure and What to Do?
11 min.
Ongoing Trials in CTO PCI: Ischemia-CTO, Co-CTO, Invest-CTO, STAR
16 min.
Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)
15 min.
Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial
15 min.
Advances in Holographic Imaging for Procedural Planning and Guidance (Realview)
12 min.
Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial
11 min.
An Optical Coherence Tomography Guided Non-Stenting Reperfusion Strategy in Patients with STEMI— A Prospective, Multi-Centre, Observational Study (EROSION II)
14 min.
First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)
8 min.
SpectraWAVE - HyperVue Imaging System
11 min.
Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
9 min.
Physiology to Optimize PCI: Lessons Learnt From Define-GPS
11 min.
Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry
15 min.
Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial
24 min.
Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial
14 min.
The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration
18 min.
Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial
15 min.
How I Have Started to Use DCB’s: A Look into the Future
15 min.
AGENT-IDE Deeper Dive: Key Subgroups and Perspectives
19 min.
AGENT-IDE Data Dive: Background, Trial Design, and Primary Results
11 min.
Current Treatment of In-Stent Restenosis: What the Rest of the World Does
13 min.
Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial
22 min.
Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial
18 min.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis
20 min.
Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction
9 min.
A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study
13 min.
We Need More Data Following REVIVED: Unanswered Questions, Current and Future Trials
12 min.
Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?
14 min.
Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?
13 min.
Ionir Ultrathin Polymer Mesh Coronary DES
6 min.
Immediate and Follow-Up Outcomes of Drug-Coated Balloon Angioplasty in de Novo Long Lesions on Large Coronary Arteries
8 min.
Drug-Coated Balloon Angioplasty For De Novo Lesions on Left Anterior Descending Artery
8 min.
Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study
10 min.
Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis (CVT-ISR Study)
14 min.
Treatment of Coronary De-Novo Lesions by a Sirolimus or a Paclitaxel Coated Balloon in a European Population
14 min.
A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial
19 min.
Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)
13 min.
Unloading in AMI: Changing the Paradigm from DTB to DTU
9 min.
Debate: Revascularization in Chronic Heart Failure after REVIVED - Revascularize!
5 min.
Debate: Revascularization in Chronic Heart Failure after REVIVED - is GDMT enough?!
4 min.
Latest Data From REVIVED
7 min.
How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?
12 min.
Novel Approaches to Reduce and Reverse Bleeding in Complex PCI
8 min.
Revascularization in LV Systolic Dysfunction: Revived or Dead?
12 min.